P1239: TISLELIZUMAB, A PD-1 INHIBITOR FOR RELAPSED/REFRACTORY MATURE T- AND NK-CELL NEOPLASMS: RESULTS FROM A PHASE 2 STUDY

• E. Bachy,
• K. J. Savage,
• H. Huang,
• Y. L. Kwong,
• G. Gritti,
• Q. Zhang,
• A. M. Liberati,
• J. Cao,
• H. Yang,
• S. Hao,
• J. Hu,
• K. Zhou,
• F. Russo,
• H. Zhang,
• W. Sang,
• J. Ji,
• A. J. M. Ferreri,
• G. L. Damaj,
• H. Liu,
• W. Zhang,
• X. Ke,
• C. Ghiggi,
• S. Huang,
• X. Li,
• H. Yao,
• J. Paik,
• W. Novotny,
• W. Zhou,
• H. Zhu,
• J. Huang,
• P. L. Zinzani

Affiliations

E. Bachy

1 Hematology Department, Lyon Sud Hospital and Claude Bernard University Lyon 1, Lyon, France

K. J. Savage

2 Department of Medical Oncology, BC Cancer, Vancouver, Canada

H. Huang

3 Sun Yat-Sen University Cancer Center, Guangzhou

Y. L. Kwong

4 Queen Mary Hospital, Hong Kong, China

G. Gritti

5 ASST Papa Giovanni XXIII, Lombardia, Italy

Q. Zhang

6 Harbin Medical University Cancer Hospital, Harbin, China

A. M. Liberati

7 Azienda Ospedaliera Santa Maria Terni, Terni, Italy

J. Cao

8 Fudan University Shanghai Cancer Center, Shanghai

H. Yang

9 The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou

S. Hao

10 Xin Hua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

J. Hu

11 Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou

K. Zhou

12 Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China

F. Russo

13 Ospedale Maggiore, Ematologia e Centro Trapianti Midollo Osseo (CTMO), AOI Parma, Italy

H. Zhang

14 Tianjin Medical University Cancer Institute & Hospital, Tianjin

W. Sang

15 The Affiliated Hospital of Xuzhou Medical University, Xuzhou

J. Ji

16 West China Hospital, Sichuan University, Chengdu, China

A. J. M. Ferreri

17 Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

G. L. Damaj

18 Institut d’Hematologie de Basse Normandie, Caen, France

H. Liu

19 Beijing Hospital, Beijing

W. Zhang

20 Peking Union Medical College Hospital

X. Ke

21 Peking University Third Hospital, Shanghai, China

C. Ghiggi

22 Ospedale Policlinico San Martino, Genova, Italy

S. Huang

23 BeiGene (Shanghai) Co., Ltd., Shanghai, China

X. Li

23 BeiGene (Shanghai) Co., Ltd., Shanghai, China

H. Yao

23 BeiGene (Shanghai) Co., Ltd., Shanghai, China

J. Paik

24 BeiGene USA, Inc., San Mateo, CA, United States of America

W. Novotny

24 BeiGene USA, Inc., San Mateo, CA, United States of America

W. Zhou

23 BeiGene (Shanghai) Co., Ltd., Shanghai, China

H. Zhu

23 BeiGene (Shanghai) Co., Ltd., Shanghai, China

J. Huang

24 BeiGene USA, Inc., San Mateo, CA, United States of America

P. L. Zinzani

25 Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy